Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial
JAMA Neurol 2021 Mar 01;78(3)293-301, R Sperling, D Henley, PS Aisen, R Raman, MC Donohue, K Ernstrom, MS Rafii, J Streffer, Y Shi, K Karcher, N Raghavan, Y Tymofyeyev, J Bogert, HR Brashear, G Novak, J Thipphawong, ZS Saad, H Kolb, H Rofael, P Sanga, G RomanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.